Zkusit zdarma
Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc.

PLRX
Cena:
$ 1.21
-0.02 (-1.63%)
Valuace
70
Růst
53
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Pliant Therapeutics, Inc. (PLRX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Pliant Therapeutics, Inc. (PLRX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

19:10 22-05-2026

Pliant Therapeutics, Inc. (PLRX) Presents at RBC Capital Markets Global Healthcare Conference 2026 T...

Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

17:29 21-05-2026

Highlights FORTIFY, the Phase 1b indication expansion trial of PLN-101095  enrolling patients with ...

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

16:05 11-05-2026

First participant dosed in FORTIFY, a Phase 1b indication expansion trial of PLN-101095 Oral present...

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

13:31 18-04-2026

Confirmed responses deepened with an average maximum tumor reduction from baseline of 89% and median...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of “Reduce” by Analysts

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of “Reduce” by Analysts

4:27 15-04-2026

Shares of Pliant Therapeutics, Inc. (NASDAQ: PLRX - Get Free Report) have been assigned an average r...

Head-To-Head Review: Pliant Therapeutics (NASDAQ:PLRX) versus Dermata Therapeutics (NASDAQ:DRMA)

Head-To-Head Review: Pliant Therapeutics (NASDAQ:PLRX) versus Dermata Therapeutics (NASDAQ:DRMA)

1:12 21-03-2026

Dermata Therapeutics (NASDAQ: DRMA - Get Free Report) and Pliant Therapeutics (NASDAQ: PLRX - Get Fr...

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results

16:05 11-03-2026

PLN-101095 Phase 1 data showed deep and durable ongoing responses in checkpoint inhibitor refractory...

Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration

Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration

1:28 24-02-2026

Pliant Therapeutics trades at a deep discount to net cash after Bexotegrast's Phase 3 failure, with ...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Short Interest Up 21.0% in January

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Short Interest Up 21.0% in January

4:34 05-02-2026

Pliant Therapeutics, Inc. (NASDAQ: PLRX - Get Free Report) was the recipient of a large increase in ...

Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors

Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors

13:53 04-12-2025

Pliant Therapeutics, Inc. (NASDAQ: PLRX) is capturing attention with promising trial results for its...

Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

7:30 04-12-2025

One complete response and three partial responses observed  in heavily pretreated ICI-secondary ref...

Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference

Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference

8:30 01-12-2025

SOUTH SAN FRANCISCO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a c...

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

16:05 06-11-2025

Oncology program advancing with data expected in the fourth quarter 2025 BEACON-IPF close out activi...

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

16:05 07-08-2025

BEACON-IPF close out activities continue Previously announced workforce and operational realignment ...

Pliant Therapeutics Provides Update on BEACON-IPF

Pliant Therapeutics Provides Update on BEACON-IPF

16:05 27-06-2025

Bexotegrast development in IPF discontinued Clinical oncology program and early-stage programs conti...

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference

16:03 21-05-2025

SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLR...

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

16:05 08-05-2025

Activities supporting the close out of BEACON-IPF continue; topline data  expected in the second qu...

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

16:05 01-05-2025

-  Implementation of cost reduction initiatives to position Pliant for execution of late-stage clin...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. – PLRX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. – PLRX

12:01 25-04-2025

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX

10:30 23-04-2025

NEW YORK, NY / ACCESS Newswire / April 23, 2025 / Pomerantz LLP is investigating claims on behalf of...

close

PLIANT THERAPEUTICS ANNOUNCES INTERIM DATA FROM PLN-101095 IN PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR-REFRACTORY ADVANCED SOLID TUMORS

04-12-2025
ONE COMPLETE RESPONSE AND THREE PARTIAL RESPONSES OBSERVED  IN HEAVILY PRETREATED ICI-SECONDARY REF...
Více zde

PLIANT THERAPEUTICS TO PARTICIPATE IN THE PIPER SANDLER HEALTHCARE CONFERENCE

01-12-2025
SOUTH SAN FRANCISCO, DEC. 01, 2025 (GLOBE NEWSWIRE) -- PLIANT THERAPEUTICS, INC. (NASDAQ: PLRX), A C...
Více zde

PLIANT THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

06-11-2025
ONCOLOGY PROGRAM ADVANCING WITH DATA EXPECTED IN THE FOURTH QUARTER 2025 BEACON-IPF CLOSE OUT ACTIVI...
Více zde

PLIANT THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

07-08-2025
BEACON-IPF CLOSE OUT ACTIVITIES CONTINUE PREVIOUSLY ANNOUNCED WORKFORCE AND OPERATIONAL REALIGNMENT ...
Více zde

PLIANT THERAPEUTICS PROVIDES UPDATE ON BEACON-IPF

27-06-2025
BEXOTEGRAST DEVELOPMENT IN IPF DISCONTINUED CLINICAL ONCOLOGY PROGRAM AND EARLY-STAGE PROGRAMS CONTI...
Více zde

PLIANT THERAPEUTICS PRESENTS CLINICAL AND PRECLINICAL DATA AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE

21-05-2025
SOUTH SAN FRANCISCO, CALIF., MAY 21, 2025 (GLOBE NEWSWIRE) -- PLIANT THERAPEUTICS, INC. (NASDAQ: PLR...
Více zde

PLIANT THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

08-05-2025
ACTIVITIES SUPPORTING THE CLOSE OUT OF BEACON-IPF CONTINUE; TOPLINE DATA  EXPECTED IN THE SECOND QU...
Více zde

PLIANT THERAPEUTICS ANNOUNCES STRATEGIC REALIGNMENT OF WORKFORCE AND OPERATIONS

01-05-2025
-  IMPLEMENTATION OF COST REDUCTION INITIATIVES TO POSITION PLIANT FOR EXECUTION OF LATE-STAGE CLIN...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS, INC. – PLRX

25-04-2025
NEW YORK, APRIL 25, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS, INC. - PLRX

23-04-2025
NEW YORK, NY / ACCESS NEWSWIRE / APRIL 23, 2025 / POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS, INC. - PLRX

21-04-2025
NEW YORK, APRIL 21, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS, INC. - PLRX

21-04-2025
NEW YORK, APRIL 21, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS, INC. - PLRX

20-04-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / APRIL 20, 2025 / POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHA...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS, INC. - PLRX

18-04-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / APRIL 18, 2025 / POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHA...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS, INC. - PLRX

17-04-2025
NEW YORK, APRIL 17, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS, INC. - PLRX

16-04-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / APRIL 16, 2025 / POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHA...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS - ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS, INC. - PLRX

15-04-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / APRIL 15, 2025 / POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHA...
Více zde

PLIANT THERAPEUTICS ANNOUNCES UPCOMING PRESENTATIONS AT THE 2025 AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE

07-04-2025
SOUTH SAN FRANCISCO, CALIF., APRIL 07, 2025 (GLOBE NEWSWIRE) -- PLIANT THERAPEUTICS, INC. (NASDAQ: P...
Více zde

INVESTOR ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS

05-04-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / APRIL 5, 2025 / FARUQI & FARUQI, LLP SECURITIES LITIGATION PAR...
Více zde

INVESTOR ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS

28-03-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON  ENCOURAGES INVESTORS WHO SU...
Více zde

INVESTOR ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS – PLRX

26-03-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFF...
Více zde

INVESTOR ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS

23-03-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFF...
Více zde

INVESTOR ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS

19-03-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFF...
Více zde

PLIANT THERAPEUTICS ANNOUNCES INTERIM PHASE 1 DATA FOR PLN-101095 IN PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR-REFRACTORY ADVANCED SOLID TUMORS

17-03-2025
ANTITUMOR ACTIVITY OBSERVED WITH CONFIRMED PARTIAL RESPONSES IN 50% OF PATIENTS AT HIGHEST DOSE TEST...
Více zde

INVESTIGATION ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS

16-03-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER  JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SU...
Více zde

INVESTOR ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS

15-03-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFF...
Více zde

SHAREHOLDER REMINDER: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS

13-03-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON  ENCOURAGES INVESTORS WHO SU...
Více zde

PLIANT THERAPEUTICS ADOPTS LIMITED DURATION STOCKHOLDER RIGHTS AGREEMENT

13-03-2025
SOUTH SAN FRANCISCO, CALIF., MARCH 13, 2025 (GLOBE NEWSWIRE) -- PLIANT THERAPEUTICS, INC. (NASDAQ: P...
Více zde

INVESTOR ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS

09-03-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFF...
Více zde

INVESTOR ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PLIANT THERAPEUTICS

05-03-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFF...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-12-16 00:00:008-KStáhnout
2025-12-08 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-10-24 01:00:008-KStáhnout
2025-10-24 00:00:008-KStáhnout
2025-10-20 01:00:008-KStáhnout
2025-10-20 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-09 01:00:008-KStáhnout
2025-06-09 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-05-01 01:00:008-KStáhnout
2025-05-01 00:00:008-KStáhnout
2025-03-13 00:00:008-KStáhnout
2025-03-12 23:00:008-KStáhnout
2025-03-03 00:00:008-KStáhnout
2025-03-03 00:00:0010-KStáhnout
2025-03-02 23:00:008-KStáhnout
2025-03-02 23:00:0010-KStáhnout
2025-02-13 00:00:008-KStáhnout
2025-02-12 23:00:008-KStáhnout
2025-02-10 00:00:008-KStáhnout
2025-02-09 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-09-27 01:00:008-KStáhnout
2024-09-27 00:00:008-KStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-07-15 01:00:008-KStáhnout
2024-07-15 00:00:008-KStáhnout
2024-06-14 01:00:008-KStáhnout
2024-06-14 00:00:008-KStáhnout
2024-05-14 01:00:008-KStáhnout
2024-05-14 00:00:008-KStáhnout
2024-05-06 01:00:008-KStáhnout
2024-05-06 01:00:0010-QStáhnout
2024-05-06 00:00:008-KStáhnout
2024-05-06 00:00:0010-QStáhnout
2024-03-12 00:00:008-KStáhnout
2024-03-11 23:00:008-KStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-27 00:00:0010-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-26 23:00:0010-KStáhnout
2024-02-05 00:00:008-KStáhnout
2024-02-04 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-10-03 01:00:008-KStáhnout
2023-10-03 00:00:008-KStáhnout
2023-09-26 01:00:008-KStáhnout
2023-09-26 00:00:008-KStáhnout
2023-08-09 01:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:008-KStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-06-08 01:00:008-KStáhnout
2023-06-08 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-05-01 01:00:008-KStáhnout
2023-05-01 00:00:008-KStáhnout
2023-03-09 00:00:008-KStáhnout
2023-03-09 00:00:0010-KStáhnout
2023-03-08 23:00:008-KStáhnout
2023-03-08 23:00:0010-KStáhnout
2023-03-08 00:00:008-KStáhnout
2023-03-07 23:00:008-KStáhnout
2023-02-23 00:00:008-KStáhnout
2023-02-22 23:00:008-KStáhnout
2023-01-25 00:00:008-KStáhnout
2023-01-24 23:00:008-KStáhnout
2023-01-23 00:00:008-KStáhnout
2023-01-22 23:00:008-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-11-18 00:00:008-KStáhnout
2022-11-17 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-08 00:00:0010-QStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-07 23:00:0010-QStáhnout
2022-09-16 01:00:008-KStáhnout
2022-09-16 00:00:008-KStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-07-14 01:00:008-KStáhnout
2022-07-14 00:00:008-KStáhnout
2022-07-11 01:00:008-KStáhnout
2022-07-11 00:00:008-KStáhnout
2022-06-17 01:00:008-KStáhnout
2022-06-17 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 00:00:008-KStáhnout
2022-03-01 00:00:0010-KStáhnout
2022-02-28 23:00:0010-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-09 00:00:0010-QStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-08 23:00:0010-QStáhnout
2021-09-07 01:00:008-KStáhnout
2021-09-07 00:00:008-KStáhnout
2021-08-09 01:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:008-KStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-07-02 01:00:008-KStáhnout
2021-07-02 00:00:008-KStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 01:00:0010-QStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-10 00:00:0010-QStáhnout
2021-03-16 00:00:008-KStáhnout
2021-03-16 00:00:0010-KStáhnout
2021-03-15 23:00:008-KStáhnout
2021-03-15 23:00:0010-KStáhnout
2021-01-13 00:00:008-KStáhnout
2021-01-12 23:00:008-KStáhnout
2020-12-21 00:00:008-KStáhnout
2020-12-20 23:00:008-KStáhnout
2020-11-10 00:00:008-KStáhnout
2020-11-10 00:00:0010-QStáhnout
2020-11-09 23:00:008-KStáhnout
2020-11-09 23:00:0010-QStáhnout
2020-08-11 01:00:008-KStáhnout
2020-08-11 01:00:0010-QStáhnout
2020-08-11 00:00:008-KStáhnout
2020-08-11 00:00:0010-QStáhnout
preloader